| Angela Yuen, PHARM D | |
|
3855 Health Sciences Dr, La Jolla, CA 92093-1503 | |
| (858) 822-6094 | |
| Not Available |
| Full Name | Angela Yuen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3855 Health Sciences Dr, La Jolla, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376096503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH60661993 (Washington) | Secondary |
| 183500000X | Pharmacist | 75646 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Yuen, PHARM D 501 Se 123rd Ave, Apt. F37, Vancouver, WA 98683-4034 Ph: () - | Angela Yuen, PHARM D 3855 Health Sciences Dr, La Jolla, CA 92093-1503 Ph: (858) 822-6094 |
News Archive
Colonoscopy is regarded as the most thorough way to screen for colon cancer but the potentially life-saving procedure can also be painful.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that it has received a strategic investment from Medtronic, Inc., the global leader in medical device technology and therapies designed to treat chronic diseases.
Nano Bridging Molecules SA, A Swiss med-tech company announced that it has received CE Mark (Conformité Européenne) approval to begin marketing its SurfLink® Dental product. With its bio mimicking properties, SurfLink® Dental has been shown to allow for natural and permanent integration of dental implants for the first time. Bone seems to perceive the SurfLink® Dental product as ‘body-like' and integrates the implant with a natural healing process, resulting in a quicker healing and a more stable integration, than without this product.
BioLineRx, a biopharmaceutical development company, announced today the publication of results from the Phase II EAGLE clinical trial for BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia, showing that BL-1020 is safe and effective in improving schizophrenia, in addition to improving cognitive impairment associated with this condition.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced CE Mark approval for the Aptus EndoStapling System. The innovative helical staple technology enables independent endograft fixation, and is designed to mimic the hand suturing performed during open surgical repair of abdominal aortic aneurysms.
› Verified 6 days ago
Amy Waller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7544 Girard Ave, La Jolla, CA 92037 Phone: 858-454-0932 Fax: 858-454-8518 | |
Arthur Shen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9350 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-8512 Fax: 858-657-8621 | |
Pablina Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3855 Health Sciences Dr # 845, La Jolla, CA 92093 Phone: 858-822-6091 Fax: 858-822-6092 | |
Hue Nhan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7525 Eads Ave, La Jolla, CA 92037 Phone: 858-551-8698 | |
Alexander Kent Yee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-249-5682 | |
Paricheh Azimi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-249-6181 | |
Ashley Ta, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-7000 |